Amgen AMGN
NASDAQ AMGN
$403.04 -4.23 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amgen (AMGN) Cash & Current Investments (2009 - 2026)

Updated

Amgen's Cash & Current Investments was $13.99 billion in Q2 2026, up 74.3% from $8.03 billion a year earlier and up 16.2% from the prior quarter.

Analysis

Amgen (AMGN) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Amgen came in at $9.13 billion, down 23.8% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $11.97 billion in FY2024 (+9.4%), $10.94 billion in FY2023 (+17.6%), $9.31 billion in FY2022 (+15.8%) and $8.04 billion in FY2021 (-24.5%).
  • The Q2 2026 figure marks the highest quarterly Cash & Current Investments since Q3 2023.
  • Compared with a year earlier, Cash & Current Investments was higher in four of the last eight quarters, with growth averaging 0.5%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2023 (growth of 382.9%); the worst was Q3 2024 (a decline of 74.1%).
  • Per Business Quant data, AMGN's Cash & Current Investments in the three quarters before Q2 2026 was $12.04 billion (Q1 2026), $9.13 billion (Q4 2025) and $9.45 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 7.85 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.99 Bn
Mar 31, 2026 12.04 Bn
Dec 31, 2025 9.13 Bn
Sep 30, 2025 9.45 Bn
Jun 30, 2025 8.03 Bn
Mar 31, 2025 8.81 Bn
Dec 31, 2024 11.97 Bn
Sep 30, 2024 9.01 Bn
Jun 30, 2024 9.30 Bn
Mar 31, 2024 9.71 Bn
Dec 31, 2023 10.94 Bn
Sep 30, 2023 34.74 Bn
Jun 30, 2023 34.25 Bn
Mar 31, 2023 31.60 Bn
Dec 31, 2022 9.31 Bn
Sep 30, 2022 11.48 Bn
Jun 30, 2022 7.18 Bn
Mar 31, 2022 6.54 Bn
Dec 31, 2021 8.04 Bn
Sep 30, 2021 12.92 Bn
API Access

Amgen Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AMGN&period=max&api_key=YOUR_API_KEY